SUMMARY Blood spot 17-hydroxyprogesterone concentrations were measured serially over 24 hours in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency before they started treatment with glucocorticoids, and the development of diurnal rhythm in pituitary-adrenal activity was studied. Five infants aged 2 to 26 days showed an intradiem variation of 17-hydroxyprogesterone concentrations within the diagnostic range but without a characteristic diurnal pattern. Blood spot 17-hydroxyprogesterone values in a further eight patients aged 3 months to 6-5 years showed a diurnal rhythm, with high concentrations in the morning and a nadir in the evening. The 
endogenous concentration of adrenocorticotrophic hormone.
The activity of the pituitary-adrenal axis has a characteristic diurnal pattern in adults.' In contrast, conflicting results have been published on the development of diurnal rhythms in the secretion of adrenocorticotrophic hormone and adrenocortical steroids in infancy. [2] [3] [4] Raised morning and low evening concentrations of adrenocorticotrophic and glucocorticoid hormones have been found in patients with congenital adrenal hyperplasia.5 Plasma concentrations of 17-alpha-hydroxyprogesterone (17-OHP) are considerably raised in patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. Peak values occur in the morning with low concentrations in the evening in adolescent and adult patients before treatment,6 during inadequate treatment,78 and after withdrawal of glucocorticoid treatment.9 1( This paper reports serial measurements of plasma 17-OHP concentrations over a 24 hour period, performed before treatment was started in a group of infants and children with congenital adrenal hyperplasia. The data provide further information on the development and acquisition of diurnal periodicity in pituitary-adrenal activity during early postnatal life.
Materials and methods
Patients. Thirteen patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency were investigated. They had presented with ambiguous external genitalia or salt wasting crises, or both, in the newborn period, or with signs of precocious puberty in older children. At the time of the study there were five infants less than 4 weeks old (all salt losers) and eight children aged 3 months to 6-5 years (one salt loser, seven non-salt losers).
Capillary blood samples were collected onto filter paper every two to four hours over a 24 hour period for serial 17-OHP measurements. The 24 hour sampling protocol was repeated in some cases.
To obtain reference values, the diurnal variation of blood spot 17-OHP concentrations was studied in 20 infants (10 aged 2 days to 6 weeks and 10 aged 3 to 12 months) and 9 children (aged 3 to 12 years) investigated for various disorders but subsequently shown to have no endocrine dysfunction.
To compare serum and blood spot 17-OHP measurements, 64 morning venous samples were collected simultaneously with blood spot samples from 20 patients with congenital adrenal hyperplasia aged 2 days to 15 years before and during glucocorticoid treatment. 17 -OHP determinations were performed by a non-chromatographic radioimmunoassay. The assay technique has previously been described in detail. '2 All samples collected from each patient were analysed simultaneously in the same assay. Intraassay coefficients of variation for blood spot 17-OHP were 12-2%, 11*5%, and 10-9% at concentrations of 23 (n=10), 152 (n=10), and 670 (n=10) nmolIl respectively. Data on the stability of 17-OHP in blood spots and the sensitivity and interassay precision of the method have been published previously. 12 13 The daily variation of 17-OHP concentrations in each patient was examined by determining whether the blood spot 17-OHP concentration at a given time of the day differed by more than twice the intra-assay variance (±23%) from the mean value (weighted average) observed in the same patient during the 24 hour period.
Results
There was a close correlation between the 17-OHP measurements, determined by extracting a known amount of serum and using a standard disc with dried blood, over a wide range of serum concentrations (1 to 1870 nmol/l; (Fig. 5 ). 
There was no significant difference between daily profiles of blood 17-OHP when repeated in the same patient on two different days.
Discussion
There are no previous studies reporting the diurnal variation in pituitary-adrenal activity in untreated newborns and infants with congenital adrenal hyperplasia. To study the diurnal pattern of 17-OHP concentration in newborns, infants, and children with this disorder a technique using a small amount of capillary blood is required. The blood spot 17-OHP method was first recommended for congenital adrenal hyperplasia screening by Pang et 
